VALUE-BASED PRICING IN THE UK: DEVELOPING AN EVALUATION FRAMEWORK FOR BURDEN OF ILLNESS

被引：0
|
作者：
Easley, C. [1 ]
Tang, J. [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.026
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A236 / A236
页数：1
相关论文
共 50 条
  • [1] Value-based pricing of drugs in the UK
    Webb, David J.
    Walker, Andrew
    LANCET, 2007, 369 (9571): : 1415 - 1416
  • [2] UK parses merits of value-based drug pricing
    Nuala Moran
    Nature Biotechnology, 2007, 25 : 369 - 370
  • [3] UK parses merits of value-based drug pricing
    Moran, Nuala
    NATURE BIOTECHNOLOGY, 2007, 25 (04) : 369 - 370
  • [4] A NEW VALUE-BASED PRICING FRAMEWORK FOR THE OPTIMAL PRICING OF PHARMACEUTICAL ASSETS
    Hawryluk, E. A.
    Malhotra, M.
    Chawla, V
    Doyle, J.
    VALUE IN HEALTH, 2012, 15 (07) : A489 - A490
  • [5] Towards value-based pricing - An integrative framework for decision making
    Hinterhuber, A
    INDUSTRIAL MARKETING MANAGEMENT, 2004, 33 (08) : 765 - 778
  • [6] Developing a value-based service delivery system framework
    Quoquab, F.
    Rasid, S. Z. A.
    Basiruddin, R.
    RECENT TRENDS IN SOCIAL AND BEHAVIOUR SCIENCES, 2014, : 197 - 201
  • [7] Early evaluation and value-based pricing of regenerative medicine technologies
    Koerber, Florian
    Rolauffs, Bernd
    Rogowski, Wolf
    REGENERATIVE MEDICINE, 2013, 8 (06) : 747 - 758
  • [8] SHORTCOMINGS OF EQ-5D IN A VALUE-BASED PRICING FRAMEWORK
    Tordrup, D.
    Mossman, J.
    Kanavos, P.
    VALUE IN HEALTH, 2013, 16 (03) : A10 - A11
  • [9] VALUE-BASED PRICING IN THE UK AND POTENTIAL PATIENT ACCESS HURDLES TO INNOVATIVE DRUGS
    Papadopoulou, K.
    Grosvenor, A.
    VALUE IN HEALTH, 2013, 16 (07) : A492 - A492
  • [10] THE VALUE OF INNOVATION UNDER VALUE-BASED PRICING
    Moreno, S. G.
    VALUE IN HEALTH, 2016, 19 (03) : A296 - A296
12345